a water-soluble vitamin
marker for systemic lupus erythematosus (SLE)
Antigen Made From: Medium grain and basmati white Rice Associated With: - Allergy/hypersensitivity - Enterocolitis3 Known Cross-Reactions: Wheat; Corn/Maize; Millet; Soybean; Gliadin; Glutamic Acid Decarboxylase-65; Triiodothyronine (T3) Clinical Significance: The presence of antibodies to Rice is an indication of food immune reactivity. The offending food and its known cross-reactive foods should be eliminated from the diet. Adverse reactions to Rice have been reported. Despite its cross-reactivity to wheat, Rice is often over-consumed in a gluten-free diet, which can result in the patient developing an immune reactivity to Rice. References: 1. Asero et al. Rice: another potential cause of food allergy in patients sensitized to lipid transfer protein. Int Arch Allergy Immunol, 2007; 143:69-74. 2. Lehrer et al. Corn Allergens: IgE antibody reactivity and cross-reactivity with rice, soy, and peanut. Int Arch Allergy Immunol, 1999; 118:298-299. 3. Gray et al. Rice-induced enterocolitis in an infant: TH1/TH2 cellular hypersensitivity and absent IgE reactivity. Ann Allergy Asthma Immunol, 2004; 93:601–605. 4. Urisu et al. 16-kilodalton rice protein is one of the major allergens in rice grain extract and responsible for cross-allergenicity between cereal grains in the poaceae family. Int Arch Allergy Immunol, 1991; 96(3):244-252. 5. Yamada et al. The involvement of rice protein 16KD in cross-allergenicity between antigens in rice, wheat, corn, Japanese millet, Italian millet. [Japanese] Arerugi, 1991; 40(12):1485-1492. 6. Hemmer et al. Food Allergy to millet and cross-reactivity with rice, corn and other cereals. Allergology International, 2017; 66:490-492. 7. Vojdani and Tarash. Cross-reaction between gliadin and different food and tissue antigens, Food Nutri Sci, 2013; 4:20-32. 8. Kharrazian, et al. Detection of islet cell immune reactivity with low glycemic index foods: is this a concern for type 1 diabetes? J Diabetes Res, 2017; 2017:4124967. 9. Kharrazian, et al. Immunological reactivity using monoclonal and polyclonal antibodies of autoimmune thyroid target sites with dietary proteins. J Thyroid Res, 2017; 2017:4354723.
Rice IgG reactivity marker
Elevated antibody levels can be clinically significant
the etiological agent of murine typhus
What is Rickettsia typhi Surface Antigen – IgM? Rickettsia typhi is the bacterium that causes murine typhus, a flea-borne illness most commonly found in warm, coastal regions of the world, including parts of the southern United States (e.g., Texas and California). It is primarily transmitted to humans by the bite of fleas infected from rodents or, occasionally, opossums or other small mammals. The Surface Antigen – IgM test detects IgM antibodies produced by your immune system in response to proteins on the surface of Rickettsia typhi. IgM antibodies are typically the first to appear during an infection, usually within the first 1 to 2 weeks of exposure. A positive result generally suggests a recent or active infection.
The Right Coronary Artery (RCA) is a pivotal vessel in the cardiovascular system, playing a central role in the assessment of heart health during a Coronary Calcium Scan. This scan, utilizing computed tomography (CT) technology, is designed to detect the presence of calcium deposits within the coronary arteries, indicative of atherosclerotic plaque. The RCA originates from the right aortic sinus and courses along the right atrioventricular groove, supplying blood to the right atrium, right ventricle, part of the left ventricle, the sinoatrial (SA) node in most individuals, and the atrioventricular (AV) node. The presence of calcification in the RCA, as revealed in the scan, signifies the extent of coronary artery disease (CAD) in this vessel. This is critical, as the RCA's involvement in CAD can lead to various clinical manifestations, including right-sided heart problems, arrhythmias, and, in severe cases, myocardial infarction. The calcium score obtained for the RCA contributes to the overall coronary calcium score, which quantifies the burden of calcified plaque and aids in stratifying the risk of future cardiac events. A higher calcium score in the RCA correlates with an increased likelihood of CAD and potential cardiac complications. It is important to note, though, that while the Coronary Calcium Scan effectively identifies the presence and extent of calcified plaque, it does not measure the functional severity of the blockage or detect non-calcified plaque, which can also be clinically significant. Therefore, the identification of calcification in the RCA is a vital component in the early detection and management of CAD, guiding healthcare professionals in the implementation of appropriate preventive and therapeutic strategies to improve cardiovascular health and patient outcomes.
Understanding the Omega 3 (EPA+DHA) Index and Cardiovascular Risk The Omega 3 (EPA+DHA) Index is a key biomarker that measures the percentage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in red blood cell membranes. This index is directly linked to cardiovascular health, with higher levels generally associated with reduced risk of heart disease. It also provides insights into your omega-3 status, helping assess how dietary and lifestyle choices may influence cardiovascular and inflammatory health. The "Risk (Cardiovascular)" marker evaluates the likelihood of cardiovascular disease based on fatty acid imbalances. Elevated or inadequate levels of omega-3 fatty acids can signal increased risk and guide healthcare providers in making personalized recommendations. Uses of the Omega 3 and 6 Fatty Acid Test Assess Nutritional Status The test evaluates dietary intake and absorption of essential fatty acids. Deficiencies or imbalances may suggest the need for adjustments, such as increasing omega-3-rich foods or reducing omega-6-rich processed foods. Guide Treatment Decisions For individuals with cardiovascular or inflammatory conditions, test results help determine interventions, such as dietary changes, omega-3 supplementation, or other lifestyle modifications. Monitor Response to Therapy Repeated testing can assess how effective treatments—such as omega-3 supplementation or dietary shifts—are in restoring optimal fatty acid levels. Omega 3 Index Categories and Interpretation High (75th percentile): Associated with lower cardiovascular risk. Suggests sufficient intake of omega-3-rich foods like fatty fish or high-quality supplements. Low (25th percentile): Linked to increased cardiovascular risk. Indicates insufficient omega-3 intake or poor absorption. A higher Omega 3 (EPA+DHA) Index typically correlates with improved heart health, lower inflammation, and enhanced cellular function. Healthcare providers use these categories to contextualize risk and tailor recommendations. Key Considerations Dietary Impact: Your diet significantly influences Omega 3 and 6 levels. Consuming omega-3-rich foods, such as fish, walnuts, and flaxseeds, can improve your Omega 3 Index. Reducing omega-6 intake from processed foods and certain vegetable oils helps balance levels. Supplementation: Omega-3 supplements may be recommended for individuals with low dietary intake or specific medical conditions affecting fatty acid metabolism. Health Conditions: Metabolic syndrome, cardiovascular disease, and some mental health disorders can affect fatty acid levels and may require targeted interventions. Balancing Omega 3 and 6 Levels Increase Omega 3 Intake: Include fatty fish (salmon, mackerel), flaxseeds, chia seeds, and walnuts in your diet. Reduce Omega 6 Intake: Limit processed foods and oils like corn, soybean, and sunflower oil. Consider Supplementation: High-quality EPA and DHA supplements can help address deficiencies when dietary changes alone are insufficient. Treatment and Monitoring For individuals with imbalanced Omega 3 and 6 levels or those at higher cardiovascular risk: Dietary Adjustments: Focus on foods rich in omega-3 and lower in omega-6. Medical Management: Conditions like heart disease or inflammation require comprehensive treatment aligned with clinical guidelines. Regular Testing: Periodic measurement of the Omega 3 Index ensures therapies are effective and informs necessary adjustments. Note: Always interpret Omega 3 and 6 Fatty Acid test results with a healthcare provider, considering your overall health, medical history, and related lab findings.
Ristocetin Cofactor (RCoF) Test: Essential for Diagnosing von Willebrand Disease The Ristocetin Cofactor (RCoF) test is a critical diagnostic tool used to assess the functional activity of von Willebrand factor (vWF), a glycoprotein vital for blood clotting and primary hemostasis. This test is pivotal in diagnosing and managing von Willebrand disease (VWD), the most common inherited bleeding disorder, which affects up to 1% of the global population. How the RCoF Test Works The RCoF assay measures how well vWF binds to platelets to promote clot formation. Using ristocetin, a glycopeptide antibiotic, the test induces platelet aggregation in the presence of functional vWF. The degree of platelet clumping reflects vWF activity, providing a quantitative measure of its function. Key Features and Benefits Specificity: Targets vWF functionality, unlike other coagulation tests. Sensitivity: Effective in detecting type 2 VWD, where vWF is present but dysfunctional. Complementary Testing: Often paired with vWF antigen (vWF:Ag) tests to distinguish between quantitative (low vWF levels) and qualitative (dysfunctional vWF) defects. Clinical Applications The RCoF test is invaluable for: Diagnosing all types of VWD (types 1, 2, and 3). Monitoring treatment efficacy in VWD patients. Assessing bleeding risks before surgery. Detecting acquired von Willebrand syndrome in patients with other medical conditions. Limitations and Interpretation Low RCoF levels may indicate: Von Willebrand disease (types 1, 2, or 3). Acquired von Willebrand syndrome. Platelet function disorders. However, factors such as blood type, stress, and pregnancy can influence results. Thus, the RCoF test should always be interpreted alongside clinical findings and other lab results. Innovations in RCoF Testing Automated assays: Enhance reproducibility and reduce turnaround time. Recombinant ristocetin analogs: Improve test accuracy and specificity. Point-of-care testing: Enables rapid diagnosis in critical or emergency situations. Conclusion The Ristocetin Cofactor test remains a cornerstone in diagnosing and managing von Willebrand disease and related bleeding disorders. Its ability to assess the functionality of vWF makes it an indispensable resource for hematologists and hemostasis laboratories worldwide, ensuring better patient outcomes through accurate diagnosis and tailored treatment strategies.
Establish the diagnosis of infection due to Rickettsia in the spotted fever group
aid in testing for the diagnosis of Rocky Mountain Spotted Fever